TCIM
CRDF icon

TIAA CREF Investment Management’s Cardiff Oncology CRDF Stock Holding History

TIAA CREF Investment Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,060
Closed -$88K – 3141
2017
Q1 		$88K Sell
1,060
-24
-2% -$3.26K ﹤0.01% 3050
2016
Q4 		$164K Sell
1,084
-132
-11% -$30.8K ﹤0.01% 3057
2016
Q3 		$393 Sell
1,216
-714
-37% -$260K ﹤0.01% 2939
2016
Q2 		$630K Buy
1,930
+138
+8% +$47.5K ﹤0.01% 2767
2016
Q1 		$600K Sell
1,792
-496
-22% -$169K ﹤0.01% 2732
2015
Q4 		$890K Sell
2,288
-489
-18% -$192K ﹤0.01% 2643
2015
Q3 		$1.14M Buy
2,777
+1,379
+99% +$722K ﹤0.01% 2493
2015
Q2 		$1.02M Buy
+1,398
New +$992K ﹤0.01% 2690

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

TIAA CREF Investment Management's CRDF Position: Q2 2017 in Review

TIAA CREF Investment Management sold out of Cardiff Oncology (CRDF) in Q2 2017, closing a stake of 1,060 shares — an estimated $88K sold.

TIAA CREF Investment Management first reported a position in CRDF in Q2 2015 and held it in 8 quarters. The position peaked at $1.14M in Q3 2015. 48 funds tracked by Wall St. Rank hold CRDF as of Q2 2017.

  • TIAA CREF Investment Management reported no remaining Cardiff Oncology position as of Q2 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 1,060 Cardiff Oncology shares in Q2 2017, an estimated $88K.
  • TIAA CREF Investment Management first reported a position in Cardiff Oncology in Q2 2015 and held it in 8 quarters.
  • TIAA CREF Investment Management's Cardiff Oncology position peaked at $1.14M in Q3 2015.
  • 48 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2017.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.